Showing results (31-40 of 230) with videos related to
Sort By:
Pageof 23
Annual Review of Medicine|November 19, 2016
CAR T Cell Therapy for Solid TumorsKheng Newick, Shaun O'Brien, Edmund Moon, et al.The Lancet. Oncology|March 7, 2018
Novel therapies for malignant pleural mesotheliomaArnaud Scherpereel, Frederic Wallyn, Steven M Albelda, et al.American Journal of Respiratory Cell and Molecular Biology|February 18, 2010
Gene therapy for mesothelioma and lung cancerAnil Vachani, Edmund Moon, Elliot Wakeam, et al.Science (New York, N.Y.)|March 25, 2006
Synergistic antitumor effects of immune cell-viral biotherapySteve H Thorne, Robert S Negrin, Christopher H ContagAdvances in Experimental Medicine and Biology|December 25, 2017
Oncolytic Virotherapy and the Tumor MicroenvironmentSara E Berkey, Steve H Thorne, David L BartlettJournal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2008
Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopesCarmen Garnacho, Steven M Albelda, Vladimir R Muzykantov, et al.Blood|December 7, 2002
PECAM-1-dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localizationChristopher D O'Brien, Poay Lim, Jing Sun, et al.Cancer Cell|July 5, 2016
Oncolytic Virus-Mediated Targeting of PGE2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to ImmunotherapyWeizhou Hou, Padma Sampath, Juan J Rojas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2015
Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic VirotherapyJuan J Rojas, Padma Sampath, Weizhou Hou, et al.International Journal of Molecular Sciences|March 4, 2016
Asbestos Induces Oxidative Stress and Activation of Nrf2 Signaling in Murine Macrophages: Chemopreventive Role of the Synthetic Lignan Secoisolariciresinol Diglucoside (LGM2605)Ralph A Pietrofesa, Anastasia Velalopoulou, Steven M Albelda, et al.Pageof 23